Portfolio company
NovaGo Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage biotechnology company develops human antibody therapeutics to promote nerve regeneration for patients with spinal cord injuries and strokes.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
Convelo Therapeutics
This biotechnology company develops medicines to regenerate nerve cell myelin for patients with neurological disorders, including multiple sclerosis and paediatric leukodystrophies.
Neuroplast
This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.
Novoron
The company develops lipoprotein-receptor therapies to repair central nervous system damage for patients with spinal cord injuries, multiple sclerosis and Alzheimer's disease.
Pheno Therapeutics
This biotech company develops neuroprotective and remyelinating therapies for patients with multiple sclerosis and other neurodegenerative disorders.
MindImmune Therapeutics
This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.
ONWARD Medical
This company develops spinal cord stimulation systems to restore movement and function in people with spinal cord injuries and Parkinson's disease.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
